Director/PDMR Shareholding

RNS Number : 5053O
GlaxoSmithKline PLC
11 October 2012
 



 

Notification of Transactions of Directors, Persons Discharging

Managerial Responsibility or Connected Persons

 

 

The Administrators of the GlaxoSmithKline 2009 Deferred Annual Bonus Plan (the Plan) notified the Company and the under-mentioned persons on 10 October 2012 of the following increases in their notional interests in Ordinary Shares and American Depositary Shares (ADSs) at a price of 1450.50 pence per Ordinary Share and $46.91 per ADS following the re-investment of dividends paid to shareholders on 4 October 2012.

 

 

Sir Andrew Witty

Acquisition of 1,306 Ordinary Shares under the personal contribution element of the Plan.




Acquisition of 1,306 Ordinary Shares under the matching element of the Plan (Company contribution).



Mr S Dingemans

Acquisition of 347 Ordinary Shares under the personal contribution element of the Plan.




Acquisition of 347 Ordinary Shares under the matching element of the Plan (Company contribution).



Mr S M Bicknell

Acquisition of 200 Ordinary Shares under the personal contribution element of the Plan.




Acquisition of 200 Ordinary Shares under the matching element of the Plan (Company contribution).



Mrs D P Connelly

Acquisition of 110 ADSs under the personal contribution element of the Plan.




Acquisition of 110 ADSs under the matching element of the Plan (Company contribution).



Mr M Dunoyer

Acquisition of 105 Ordinary Shares under the personal contribution element of the Plan.




Acquisition of 105 Ordinary Shares under the matching element of the Plan (Company contribution).



Mr W C Louv

Acquisition of 56 ADSs under the personal contribution element of the Plan.




Acquisition of 56 ADSs under the matching element of the Plan (Company contribution).



Mr D S Redfern

Acquisition of 242 Ordinary Shares under the personal contribution element of the Plan.




Acquisition of 242 Ordinary Shares under the matching element of the Plan (Company contribution).



Dr M M Slaoui

 

Acquisition of 447 ADSs under the personal contribution element of the Plan.




Acquisition of 447 ADSs under the matching element of the Plan (Company contribution).



Ms C Thomas 

Acquisition of 203 Ordinary Shares under the personal contribution element of the Plan.




Acquisition of 203 Ordinary Shares under the matching element of the Plan (Company contribution).



Mr D E Troy

Acquisition of 230 ADSs under the personal contribution element of the Plan.




Acquisition of 230 ADSs under the matching element of the Plan (Company contribution).



Dr P J T Vallance

Acquisition of 440 Ordinary Shares under the personal contribution element of the Plan.

 


Acquisition of 440 Ordinary Shares under the matching element of the Plan (Company contribution).



Ms E Walmsley

Acquisition of 126 Ordinary Shares under the personal contribution element of the Plan.

 


Acquisition of 126 Ordinary Shares under the matching element of the Plan (Company contribution).

 

 

The notional dividends accrued will be paid out in proportion to the percentage of the participant's deferred annual bonus holdings that will vest following the end of the relevant three year measurement period.

 

This notification relates to a transaction notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).

 

 

V A Whyte

Company Secretary

 

11 October 2012

 

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSFFLFFLBFZFBV

Companies

GSK (GSK)
UK 100

Latest directors dealings